gw8510 has been researched along with Adrenal Cortex Cancer in 1 studies
GW8510: 3' substituted indolone as a scaffold for the development of neuroprotective drug; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tabbal, H | 1 |
| Septier, A | 1 |
| Mathieu, M | 1 |
| Drelon, C | 1 |
| Rodriguez, S | 1 |
| Djari, C | 1 |
| Batisse-Lignier, M | 1 |
| Tauveron, I | 1 |
| Pointud, JC | 1 |
| Sahut-Barnola, I | 1 |
| Ragazzon, B | 1 |
| Assié, G | 1 |
| Bertherat, J | 1 |
| Lefrançois-Martinez, AM | 1 |
| Martinez, A | 1 |
| Val, P | 1 |
1 other study available for gw8510 and Adrenal Cortex Cancer
| Article | Year |
|---|---|
EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness.
Topics: Adenosine; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Cell Cycle Proteins; Cell Pr | 2019 |